CD69 is a type II membrane protein expressed as a homodimer composed of heavily glycosylated subunits. CD69 is known as an early activation marker antigen of lymphocytes,and its selective expression in in‰ammatory inˆltrates suggests that it plays a role in the pathogenesis of in‰ammatory diseases. In order to address the role of CD69 in the pathogenesis of arthritis and allergic airway in‰ammation, we established CD69 deˆcient mice. CD69 deˆcient mice displayed a markedly attenuated arthritic in‰ammatory response and airway in‰ammation. The administration of anti CD69 antibody inhibited the induction of the antigen induced airway in‰ammation and hyperresponsiveness. These results indicate that CD69 plays a crucial role in the pathogenesis of arthritis and allergic airway in‰ammation and that CD69 could be a possible therapeutic target for arthritis and asthma in human patients. 
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